All4NutraNo products in the cart.
All4NutraStartseite » Sustained Release Agent » Page 12
This is about the excipient used for achieving sustained release function undergone chemical reaction with the stabilizing agent used for the...
In this study, we explored the use of lipid mesophases (LMPs) as a biocompatible and biodegradable material for sustained drug...
Abstract The production of tailored, on-demand drug delivery systems has gained attention in pharmaceutical development over the last few years,...
To enhance the bioavailability of carborane as a potential pharmacophore for BNCT, we labeled the modified o-carborane with the near-infrared dye...
About our company The Gattefossé Group is a community of employees, all driven by a dual mission: the performance of...
Abstract Hydrophobic drugs exhibit altered bioavailability and pose other challenges at an industrial level due to their poor solubility and...
Polyelectrolyte complexes (PECs) have emerged as promising vehicles for medical applications, attributable to their non-toxicity, non-immunogenicity, and ability for controlled...
Abstract Objectives The present study is intended to develop a shell-core tablet using a hot melt extrusion (HME)-based dual-nozzle fused...
Mesalamine is a first-line drug for the treatment of inflammatory bowel diseases. However, its premature release associated with marketed formulations...
Skin cancer (SC) represents a prevalent malignancy worldwide, characterized by its high drug resistance and limited therapeutic efficacy with conventional...
Copyright: PharmaExcipients AG